DRAP Orders Recall of Selected Syringe Batches Following Quality Concerns
The Drug Regulatory Authority of Pakistan (DRAP) has directed the recall of several batches of auto-disable syringes after laboratory testing identified quality concerns.
According to an official medical product alert, the affected syringe batches did not meet required performance standards during testing. As a precautionary measure, DRAP has instructed provincial drug control authorities to stop the distribution and use of the identified products.
The authority stated that maintaining the quality and safety of medical devices is essential for public health and patient protection.
DRAP has also advised manufacturers, distributors, and healthcare facilities to remove the affected batches from circulation and follow the prescribed recall procedures.
The decision follows laboratory evaluations conducted as part of routine quality monitoring of medical products available in the market.
Officials said regulatory teams will continue monitoring medical devices to ensure compliance with safety and quality standards across the country.
